Polycythemias studied
. | Diagnosis . | Gene mutations . | Number of patients . | Sensitivity of erythroid colonies to EPO . |
---|---|---|---|---|
Primary polycythemias | PV | JAK2V617F mutation | n = 6 | Hypersensitive and EPO independent |
PFCP | EPORQ434X mutation* | n = 2 | Hypersensitive and EPO independent | |
EPOR5967insT mutation† | n = 2 | Hypersensitive and EPO independent | ||
Polycythemias with features of primary and secondary polycythemia | Congenital polycythemias due to VHL mutations | VHLR200W mutation10 (Chuvash polycythemia) | n = 2 | Hypersensitive |
VHLP138L mutation16 | n = 1 | Hypersensitive | ||
VHLT124A/L188V mutation17 | n = 2 | Hypersensitive | ||
Congenital polycythemias due to HIF2A mutation | HIF2AM353V mutation18 | n = 1 | Hypersensitive | |
HIF2AG537R mutation18 | n = 1 | Hypersensitive | ||
Congenital polycythemia | LNKI257T mutation‡ | n = 1 | Hypersensitive | |
Secondary polycythemias | Congenital polycythemia due to VHL mutation | VHLH191D mutation19 (Croatian type) | n = 2 | Normal |
Secondary polycythemia due to hypoxia | Low pO2 | n = 6 | Normal |
. | Diagnosis . | Gene mutations . | Number of patients . | Sensitivity of erythroid colonies to EPO . |
---|---|---|---|---|
Primary polycythemias | PV | JAK2V617F mutation | n = 6 | Hypersensitive and EPO independent |
PFCP | EPORQ434X mutation* | n = 2 | Hypersensitive and EPO independent | |
EPOR5967insT mutation† | n = 2 | Hypersensitive and EPO independent | ||
Polycythemias with features of primary and secondary polycythemia | Congenital polycythemias due to VHL mutations | VHLR200W mutation10 (Chuvash polycythemia) | n = 2 | Hypersensitive |
VHLP138L mutation16 | n = 1 | Hypersensitive | ||
VHLT124A/L188V mutation17 | n = 2 | Hypersensitive | ||
Congenital polycythemias due to HIF2A mutation | HIF2AM353V mutation18 | n = 1 | Hypersensitive | |
HIF2AG537R mutation18 | n = 1 | Hypersensitive | ||
Congenital polycythemia | LNKI257T mutation‡ | n = 1 | Hypersensitive | |
Secondary polycythemias | Congenital polycythemia due to VHL mutation | VHLH191D mutation19 (Croatian type) | n = 2 | Normal |
Secondary polycythemia due to hypoxia | Low pO2 | n = 6 | Normal |
Two previously unreported subjects of European descent with PFCP due to the EPOR gain-of-function EPORQ434X mutation; this mutation was previously reported in a Japanese family.14
Two Czech patients whose phenotype was previously described.15
A patient with no detectable EPOR, JAK2V617F, or JAK2 exon 12 mutations and low level of EPO (<1 mU/mL) who was heterozygous for a single-nucleotide polymorphism in exon 3 (rs147341899) in the LNK gene.